Different mitochondrial response to cisplatin and hyperthermia treatment in human AGS, Caco-2 and T3M4 cancer cell lines

Abstract

Gastrointestinal cancers (gastric, pancreatic and colorectal) are life-threatening diseases, which easily spread to peritoneal cavity (Juhl et al. in Int J Cancer 57:330-335, 1994; Schneider et al. in Gastroenterology 128:1606-1625, 2005; Geer and Brennan in Am J Surg 165:68-72 1993). Application of hyperthermal intraperitoneal chemotherapy (HIPEC) is one of the choices treating these malignancies and prolonging patient survival time. Despite numbers of clinical trials showing positive effects of HIPEC against various types of cancer, the question whether hyperthermia significantly potentiate the cytotoxicity of cisplatin remains unanswered. Little information is available on the HIPEC effect at the level of mitochondria. To define the effect of hyperthermia (40 °C and 43 °C) to cisplatin treated human gastric AGS, pancreatic T3M4 and colorectal Caco-2 cancer cells, we established an in vitro experiment, which mimics clinical HIPEC conditions. Giving the importance of mitochondrial energy metabolism in cancer, we investigated the effect of cisplatin and hyperthermia on mitochondrial Complex-I (glutamate/malate) and complex-II (succinate) dependent respiratory rates, the coupling of oxidative phosphorylation, the proton permeability of mitochondrial inner membrane and on the integrity of mitochondrial outer membrane in Caco-2, AGS and T3M4 cancer cell lines. Our main findings are: 1) treatment of cells with cisplatin causes the impairment of mitochondrial functions - the increase in the proton permeability of mitochondrial inner membrane and decrease in the oxidative phosphorylation efficiency in Caco-2, AGS and T3M4 cancer cells; 2) hyperthermia (40 °C and 43 °C) increased state 2 respiration rate only in AGS cells without any effects on Caco-2 and T3M4 cells; 3) hyperthermia in combination with cisplatin doesn't enhance cisplatin effect neither in Caco-2 and T3M4 nor in AGS cells. Thus, our results show the different mitochondrial response of gastric AGS, pancreatic T3M4 and colorectal Caco-2 cancer cells to cisplatin or/and hyperthermia - treatment. Further studies are needed to find the mechanisms of cell line - specific mitochondrial response to cisplatin and hyperthermia.

Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo

“…The diagram highlights the effect of these agents on mitochondrial function, a critical aspect of this study's findings. It shows that while HAMLET alone reduces ATP production and cell respiration, its combination with oxaliplatin further disrupts these processes, as demonstrated by our institution's previous studies with platinum-based drugs in various cancer cell lines or Wei Sun et al's study [34,35]. This combined effect impairs mitochondrial function and increases mitochondrial membrane permeability, leading to a synergistic escalation of cell death.…”

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

“…Unequivocally, cannabinoids have been demonstrated to disrupt mitochondria damage and trigger ROS production both in human primary tumors and those resistant to chemotherapeutic drugs [ 477 – 479 ]. Furthermore, many commonly used chemotherapeutic drugs have been proven to interfere with mitochondria to promote anticancer effects, including, but not limited to, cisplatin [ 480 , 481 ], doxorubicin [ 482 , 483 ], sorafenib [ 484 ], and tamoxifen [ 485 ]. This broad variety of agents provide a plethora of options for tumor therapy by targeting mitochondria.…”

From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer

“…In isolated rat mitochondria, CPT induced increased state 2 and 4 respiration [ 111 ]. In different gastrointestinal cancers, CPT interferes with mitochondrial bioenergetics by increasing the permeability of the inner mitochondrial membrane, promoting mitochondrial uncoupling, and decreasing OXPHOS function [ 112 ]. Along these same lines, rats treated with a single dose of CPT showed a reduction of state 3 respiration and inhibition of complex I and ATP synthase activity [ 113 ].…”